Annual report pursuant to Section 13 and 15(d)

Employee Benefits - Restricted Stock and Restricted Stock Units (Details)

v3.22.4
Employee Benefits - Restricted Stock and Restricted Stock Units (Details)
12 Months Ended
Dec. 31, 2022
$ / shares
shares
Restricted Stock  
Share-Based Compensation Arrangement by Share-Based Payment Award, Non-Option Equity Instruments, Outstanding [Roll Forward]  
Beginning of year (in shares) | shares 201,825
Granted (in shares) | shares 632,000
Vested and issued (in shares) | shares (133,511)
Forfeited (in shares) | shares (130,000)
End of year (in shares) | shares 570,314
Vested and unissued at end of year (in shares) | shares 169,520
Unvested at end of year (in shares) | shares 400,794
Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract]  
Beginning of year, Weighted Average Grant Date Fair Value (in dollars per share) | $ / shares $ 9.98
Granted, Weighted Average Grant Date Fair Value Per RSU (in dollars per share) | $ / shares 24.12
Vested and issued, Weighted Average Grant Date Fair Value Per RSU (in dollars per share) | $ / shares 21.79
Forfeited, Weighted Average Grant Date Fair Value Per RSU (in dollars per share) | $ / shares 26.25
End of year, Weighted Average Grant Date Fair Value (in dollars per share) | $ / shares 19.50
Vested and unissued, weighted average grant date fair value, at end of year (in dollars per share) | $ / shares 15.57
Unvested, weighted average grant date fair value, at end of year (in dollars per share) | $ / shares $ 24.20
Restricted Stock Units  
Share-Based Compensation Arrangement by Share-Based Payment Award, Non-Option Equity Instruments, Outstanding [Roll Forward]  
Beginning of year (in shares) | shares 279,891
Granted (in shares) | shares 934,538
Vested and issued (in shares) | shares (162,815)
Forfeited (in shares) | shares (348,791)
End of year (in shares) | shares 702,823
Vested and unissued at end of year (in shares) | shares 7,178
Unvested at end of year (in shares) | shares 695,645
Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract]  
Beginning of year, Weighted Average Grant Date Fair Value (in dollars per share) | $ / shares $ 155.75
Granted, Weighted Average Grant Date Fair Value Per RSU (in dollars per share) | $ / shares 79.50
Vested and issued, Weighted Average Grant Date Fair Value Per RSU (in dollars per share) | $ / shares 126.65
Forfeited, Weighted Average Grant Date Fair Value Per RSU (in dollars per share) | $ / shares 101.60
End of year, Weighted Average Grant Date Fair Value (in dollars per share) | $ / shares 82.85
Vested and unissued, weighted average grant date fair value, at end of year (in dollars per share) | $ / shares 133.85
Unvested, weighted average grant date fair value, at end of year (in dollars per share) | $ / shares $ 82.30